Pharmaceuticals

Repairing the Spine: Q&A with NervGen CEO Mike Kelly

bexib
By bexib 0 Min Read

Kelly explains how the company is taking a different approach to spinal cord injuries.

You Might Also Like

The power of protein: Biotechnology mining viruses to fight disease

About AstraZeneca’s promising cancer drug

Pharma Pulse 5/10/24: Medicare Advantage, Increased Speed ​​with Competition, Global Strategic Business Report for Anti-Obesity Drugs, and More

Drug Recall: Q&A with Beth Riggio

Pharma Pulse 6/10/24: How Serious Are You About Patient-Centricity? Mark Cuban Talks Drug Prices and More

Share This Article
Previous Article Kamala’s national security adviser points to continuity of Biden’s Russia policy
Next Article Leading with Love – Angie Turner, Executive Housekeeper
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

AI M&A deals expected to increase in 2025
Banking
Remember American Giant’s $12.98 Walmart T-shirt? They made money.
Manufacturing
What is a drafting machine?
Manufacturing
Eltropy chatbot reduces credit union call volume by 20%
Banking